_id,cohorts.0.id,cohorts.0.label,dataUseConditions.id,dataUseConditions.label,description,externalReferences.0.id,externalReferences.0.label,histologicalDiagnosis.id,histologicalDiagnosis.label,icdoMorphology.id,icdoMorphology.label,icdoTopography.id,icdoTopography.label,id,individualId,info.callsetIds.0,info.cnvstatistics.cnvcoverage,info.cnvstatistics.cnvfraction,info.cnvstatistics.delcoverage,info.cnvstatistics.delfraction,info.cnvstatistics.dupcoverage,info.cnvstatistics.dupfraction,info.legacyId.0,pathologicalStage,provenance.geoLocation.geometry.coordinates.0,provenance.geoLocation.geometry.coordinates.1,provenance.geoLocation.geometry.type,provenance.geoLocation.properties.ISO3166alpha3,provenance.geoLocation.properties.city,provenance.geoLocation.properties.country,provenance.geoLocation.properties.label,provenance.geoLocation.properties.latitude,provenance.geoLocation.properties.longitude,provenance.geoLocation.properties.precision,provenance.geoLocation.type,provenance.material.id,provenance.material.label,sampledTissue.id,sampledTissue.label,tumorGrade,updated,individualAgeAtCollection,info.tnm,pathologicalStage.id,pathologicalStage.label,pathologicalTnmFindings.0.id,pathologicalTnmFindings.0.label,tumorGrade.id,tumorGrade.label,info.death,info.followupMonths,externalReferences.1.id,externalReferences.1.label,cohorts.1.id,cohorts.1.label,cohorts.2.id,cohorts.2.label,externalReferences.0.description,externalReferences.1.description,externalReferences.2.description,externalReferences.2.id,externalReferences.2.label,info.tumorStage,info.callsetIds.1,cohorts.3.id,cohorts.3.label,externalReferences.3.description,externalReferences.3.id,externalReferences.3.label,info.provenance,provenance.populations.0.confidence,provenance.populations.0.description,provenance.populations.0.type.id,provenance.populations.0.type.label,provenance.populations.1.confidence,provenance.populations.1.description,provenance.populations.1.type.id,provenance.populations.1.type.label,externalReferences.4.description,externalReferences.4.id,externalReferences.4.label,cohorts.4.id,cohorts.4.label,info.cellLine,info.samplesource,info.seer,sex
5bab56c8727983b2e00aea46,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Angiosarcoma,PMID:15863129,"Baumhoer D, Gunawan B et al. (2005): Comparative genomic hybridization in four angiosarcomas...",NCIT:C3088,Angiosarcoma,icdom-91203,Hemangiosarcoma,icdot-C50.9,"Breast, NOS",pgxbs-kftvh1iv,pgxind-kftx2von,pgxcs-kftvrtjx,1152256671,0.401,555812827,0.193,596443844,0.207,PGX_AM_BS_AngSarc-bau-03,{},9.93,51.53,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.53,9.93,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000310,breast,{},2020-09-10 17:44:29.020000,P47Y,,,,,,,,0,37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c0727983b2e00ab0ab,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Primary multicentric angiosarcoma of bone [post chemotherapy and total body irradiation for AML],PMID:24179665,"Thariat J, Peyrottes I et al. (2013): Primary multicentric angiosarcoma of bone: true...",NCIT:C3088,Angiosarcoma,icdom-91203,Hemangiosarcoma,icdot-C40.0,bones and joints,pgxbs-kftvgiob,pgxind-kftx28pq,pgxcs-kftvm543,378950887,0.132,95417249,0.033,283533638,0.099,PGX_AM_BS_24179665-tha-angsarcA,{},7.27,43.7,Point,FRA,Nice,France,"Nice, France",43.7,7.27,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:08.067000,P70Y,,,,,,,,1,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00aea44,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Angiosarcoma,PMID:15863129,"Baumhoer D, Gunawan B et al. (2005): Comparative genomic hybridization in four angiosarcomas...",NCIT:C3088,Angiosarcoma,icdom-91203,Hemangiosarcoma,icdot-C50.9,"Breast, NOS",pgxbs-kftvh1ir,pgxind-kftx2voj,pgxcs-kftvrtiy,340879986,0.119,70027325,0.024,270852661,0.094,PGX_AM_BS_AngSarc-bau-01,{},9.93,51.53,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.53,9.93,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000310,breast,{},2020-09-10 17:44:29.017000,P57Y,,,,,,,,1,21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00aea45,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Angiosarcoma,PMID:15863129,"Baumhoer D, Gunawan B et al. (2005): Comparative genomic hybridization in four angiosarcomas...",NCIT:C3088,Angiosarcoma,icdom-91203,Hemangiosarcoma,icdot-C50.9,"Breast, NOS",pgxbs-kftvh1it,pgxind-kftx2vol,pgxcs-kftvrtjg,360477484,0.125,78706058,0.027,281771426,0.098,PGX_AM_BS_AngSarc-bau-02,{},9.93,51.53,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.53,9.93,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000310,breast,{},2020-09-10 17:44:29.018000,P33Y,,,,,,,,1,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00aea47,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Angiosarcoma [postirradiation],PMID:15863129,"Baumhoer D, Gunawan B et al. (2005): Comparative genomic hybridization in four angiosarcomas...",NCIT:C3088,Angiosarcoma,icdom-91203,Hemangiosarcoma,icdot-C50.9,"Breast, NOS",pgxbs-kftvh1iw,pgxind-kftx2vop,pgxcs-kftvrtkf,61674806,0.021,8400009,0.003,53274797,0.019,PGX_AM_BS_AngSarc-bau-04,{},9.93,51.53,Point,DEU,Goettingen,Germany,"Goettingen, Germany",51.53,9.93,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000310,breast,{},2020-09-10 17:44:29.021000,P63Y,,,,,,,,1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1564,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade I, ulna]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdb,pgxind-kftx3cy0,pgxcs-kftvw4ai,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-01,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.288000,P25Y,,,,,,NCITgrade-C28077,Grade 1,0,101,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1565,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade I, pelvis]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdc,pgxind-kftx3cy2,pgxcs-kftvw4b0,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-02,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.290000,P44Y,,,,,,NCITgrade-C28077,Grade 1,0,95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1566,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade I, femur]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfde,pgxind-kftx3cy4,pgxcs-kftvw4bh,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-03,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.291000,P46Y,,,,,,NCITgrade-C28077,Grade 1,0,95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1567,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade I, sacrum]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdg,pgxind-kftx3cy6,pgxcs-kftvw4bz,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-04,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.292000,P44Y,,,,,,NCITgrade-C28077,Grade 1,0,68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1568,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade I, talus]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdh,pgxind-kftx3cy8,pgxcs-kftvw4cg,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-05,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.294000,P39Y,,,,,,NCITgrade-C28077,Grade 1,0,31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1569,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade I, tibia]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdj,pgxind-kftx3cya,pgxcs-kftvw4cx,579836805,0.202,0,0,579836805,0.202,PGX_AM_BS_AEB-10534175-06,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.295000,P50Y,,,,,,NCITgrade-C28077,Grade 1,0,79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b156b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade I, femur]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdm,pgxind-kftx3cye,pgxcs-kftvw4dv,537100643,0.187,230823364,0.08,306277279,0.107,PGX_AM_BS_AEB-10534175-08,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.298000,P36Y,,,,,,NCITgrade-C28077,Grade 1,0,80,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b156c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade I, pelvis]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdo,pgxind-kftx3cyg,pgxcs-kftvw4ee,871242429,0.303,0,0,871242429,0.303,PGX_AM_BS_AEB-10534175-09,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.299000,P72Y,,,,,,NCITgrade-C28077,Grade 1,0,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1571,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, tibia]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdw,pgxind-kftx3cyq,pgxcs-kftvw4gw,160820851,0.056,0,0,160820851,0.056,PGX_AM_BS_AEB-10534175-14,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.306000,P37Y,,,,,,NCITgrade-C28078,Grade 2,0,61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1573,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, femur]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdz,pgxind-kftx3cyu,pgxcs-kftvw4hv,1176032468,0.409,51800051,0.018,1124232417,0.391,PGX_AM_BS_AEB-10534175-16,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.309000,P34Y,,,,,,NCITgrade-C28078,Grade 2,0,47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1574,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, humerus]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfe1,pgxind-kftx3cyw,pgxcs-kftvw4ic,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-17,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.310000,P73Y,,,,,,NCITgrade-C28078,Grade 2,0,37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1575,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, pelvis]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfe2,pgxind-kftx3cyy,pgxcs-kftvw4iu,1607831842,0.559,63249784,0.022,1544582058,0.537,PGX_AM_BS_AEB-10534175-18,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.312000,P52Y,,,,,,NCITgrade-C28078,Grade 2,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1576,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, rib I-III]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfe4,pgxind-kftx3cz0,pgxcs-kftvw4jb,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-19,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.313000,P70Y,,,,,,NCITgrade-C28078,Grade 2,0,95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1577,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, rib]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfe5,pgxind-kftx3cz2,pgxcs-kftvw4jt,286320556,0.1,0,0,286320556,0.1,PGX_AM_BS_AEB-10534175-20,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.314000,P79Y,,,,,,NCITgrade-C28078,Grade 2,0,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1578,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, spine]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfe7,pgxind-kftx3cz4,pgxcs-kftvw4ka,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-21,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.316000,P66Y,,,,,,NCITgrade-C28078,Grade 2,0,71,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1579,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, scapula]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfe9,pgxind-kftx3cz6,pgxcs-kftvw4ks,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-22a,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.317000,P39Y,,,,,,NCITgrade-C28078,Grade 2,0,94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b157b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, femur]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfec,pgxind-kftx3cza,pgxcs-kftvw4no,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-23a,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.320000,P63Y,,,,,,NCITgrade-C28078,Grade 2,0,95,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b157d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, rib X]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfef,pgxind-kftx3cze,pgxcs-kftvw4oo,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-24a,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.322000,P51Y,,,,,,NCITgrade-C28078,Grade 2,0,77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b157f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, pelvis]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfei,pgxind-kftx3czi,pgxcs-kftvw4pn,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-25a,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.325000,P36Y,,,,,,NCITgrade-C28078,Grade 2,0,56,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1581,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, ulna]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfem,pgxind-kftx3czm,pgxcs-kftvw4qn,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-26,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.328000,P46Y,,,,,,NCITgrade-C28078,Grade 2,0,142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1586,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, femur]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfeu,pgxind-kftx3czw,pgxcs-kftvw4t2,1786212027,0.621,373352757,0.13,1412859270,0.491,PGX_AM_BS_AEB-10534175-31,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.335000,P27Y,,,,,,NCITgrade-C28079,Grade 3,0,69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1589,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, rib]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfez,pgxind-kftx3d02,pgxcs-kftvw4uj,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-34,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.339000,P38Y,,,,,,NCITgrade-C28079,Grade 3,0,43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b158a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, sternum, rib IV-VI]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhff0,pgxind-kftx3d04,pgxcs-kftvw4v0,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-35,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.340000,P47Y,,,,,,NCITgrade-C28079,Grade 3,0,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b158c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, pelvis]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhff4,pgxind-kftx3d08,pgxcs-kftvw4vz,303331437,0.106,0,0,303331437,0.106,PGX_AM_BS_AEB-10534175-37,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.343000,P45Y,,,,,,NCITgrade-C28079,Grade 3,0,77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b156e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, pelvis]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdr,pgxind-kftx3cyk,pgxcs-kftvw4ff,269438906,0.094,0,0,269438906,0.094,PGX_AM_BS_AEB-10534175-11,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.302000,P32Y,,,,,,NCITgrade-C28078,Grade 2,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b156f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, pelvis]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdt,pgxind-kftx3cym,pgxcs-kftvw4fx,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-12,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.303000,P39Y,,,,,,NCITgrade-C28078,Grade 2,1,83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1570,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, tibia]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdu,pgxind-kftx3cyo,pgxcs-kftvw4gf,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-13,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.305000,P63Y,,,,,,NCITgrade-C28078,Grade 2,1,64,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1572,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, rib VIII]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfdx,pgxind-kftx3cys,pgxcs-kftvw4hd,1176759512,0.409,0,0,1176759512,0.409,PGX_AM_BS_AEB-10534175-15,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.307000,P78Y,,,,,,NCITgrade-C28078,Grade 2,1,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1582,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, femur]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfen,pgxind-kftx3czo,pgxcs-kftvw4r4,266807489,0.093,0,0,266807489,0.093,PGX_AM_BS_AEB-10534175-27,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.329000,P80Y,,,,,,NCITgrade-C28078,Grade 2,1,67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1583,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade II, tibia]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfep,pgxind-kftx3czq,pgxcs-kftvw4rl,610853469,0.212,110306090,0.038,500547379,0.174,PGX_AM_BS_AEB-10534175-28,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.330000,P43Y,,,,,,NCITgrade-C28078,Grade 2,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1584,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, femur]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfer,pgxind-kftx3czs,pgxcs-kftvw4s3,1083166967,0.377,124300124,0.043,958866843,0.334,PGX_AM_BS_AEB-10534175-29,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.332000,P51Y,,,,,,NCITgrade-C28079,Grade 3,1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1585,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, clavicle]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfes,pgxind-kftx3czu,pgxcs-kftvw4sl,1423502296,0.495,748670601,0.26,674831695,0.235,PGX_AM_BS_AEB-10534175-30,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.333000,P24Y,,,,,,NCITgrade-C28079,Grade 3,1,49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1587,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, femur]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfew,pgxind-kftx3czy,pgxcs-kftvw4tk,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-32,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.336000,P71Y,,,,,,NCITgrade-C28079,Grade 3,1,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1588,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, humerus]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhfex,pgxind-kftx3d00,pgxcs-kftvw4u1,814944810,0.283,216443197,0.075,598501613,0.208,PGX_AM_BS_AEB-10534175-33,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.337000,P43Y,,,,,,NCITgrade-C28079,Grade 3,1,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b158b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, femur]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhff2,pgxind-kftx3d06,pgxcs-kftvw4vi,251491272,0.087,0,0,251491272,0.087,PGX_AM_BS_AEB-10534175-36,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.341000,P80Y,,,,,,NCITgrade-C28079,Grade 3,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b158d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, scapula]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhff5,pgxind-kftx3d0a,pgxcs-kftvw4wg,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-38,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.344000,P72Y,,,,,,NCITgrade-C28079,Grade 3,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b158e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, humerus]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhff7,pgxind-kftx3d0c,pgxcs-kftvw4wy,966131897,0.336,154913909,0.054,811217988,0.282,PGX_AM_BS_AEB-10534175-39,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.346000,P56Y,,,,,,NCITgrade-C28079,Grade 3,1,44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b158f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, soft tissue]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvhff9,pgxind-kftx3d0e,pgxcs-kftvw4xg,1144199139,0.398,0,0,1144199139,0.398,PGX_AM_BS_AEB-10534175-40,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:44.347000,P53Y,,,,,,NCITgrade-C28079,Grade 3,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ce727983b2e00b1590,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, femur]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhffa,pgxind-kftx3d0g,pgxcs-kftvw4xx,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-41,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.349000,P74Y,,,,,,NCITgrade-C28079,Grade 3,1,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ce727983b2e00b1591,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Chondrosarcoma [grade III, sternum]",PMID:10534175,"Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...",NCIT:C2946,Chondrosarcoma,icdom-92203,"Chondrosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvhffc,pgxind-kftx3d0i,pgxcs-kftvw4ye,0,0,0,0,0,0,PGX_AM_BS_AEB-10534175-42,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,,2020-09-10 17:44:44.350000,P67Y,,,,,,NCITgrade-C28079,Grade 3,1,11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad780,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6g,pgxind-kftx2o6g,pgxcs-kftvpy7o,298676815,0.104,153502740,0.053,145174075,0.05,PGX_AM_BS_17952124-cig-03,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.970000,,,,,,,,,0,58.5,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad783,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6k,pgxind-kftx2o6m,pgxcs-kftvpy94,487916734,0.17,152807241,0.053,335109493,0.117,PGX_AM_BS_17952124-cig-06,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.974000,,,,,,,,,0,53.25,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad785,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,geo:GSE8398,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6o,pgxind-kftx2o6q,pgxcs-kftvpya3,620476283,0.216,161341,0,620314942,0.216,PGX_AM_BS_17952124-cig-08,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.977000,,,,,,,,,0,50.5,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad787,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6r,pgxind-kftx2o6u,pgxcs-kftvpyb1,0,0,0,0,0,0,PGX_AM_BS_17952124-cig-10,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.979000,,,,,,,,,0,49.75,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad788,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6t,pgxind-kftx2o6w,pgxcs-kftvpybi,157283247,0.055,12326024,0.004,144957223,0.05,PGX_AM_BS_17952124-cig-12,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.981000,,,,,,,,,0,42.5,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad789,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,geo:GSE8398,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6u,pgxind-kftx2o6y,pgxcs-kftvpybz,206106224,0.072,200111354,0.07,5994870,0.002,PGX_AM_BS_17952124-cig-13,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.982000,,,,,,,,,0,34,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad78b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6x,pgxind-kftx2o72,pgxcs-kftvpycz,145957222,0.051,999999,0,144957223,0.05,PGX_AM_BS_17952124-cig-15,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.985000,,,,,,,,,0,33.25,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad78d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv71,pgxind-kftx2o76,pgxcs-kftvpydx,155268358,0.054,155268358,0.054,0,0,PGX_AM_BS_17952124-cig-17,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.988000,,,,,,,,,0,29.5,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad78e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv72,pgxind-kftx2o78,pgxcs-kftvpyee,154493234,0.054,154472050,0.054,21184,0,PGX_AM_BS_17952124-cig-18,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.989000,,,,,,,,,0,17,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad790,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv75,pgxind-kftx2o7c,pgxcs-kftvpyfd,164068271,0.057,156442174,0.054,7626097,0.003,PGX_AM_BS_17952124-cig-20,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.992000,,,,,,,,,0,6.5,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad795,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,geo:GSE8398,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv7d,pgxind-kftx2o7m,pgxcs-kftvpyht,236927360,0.082,201637362,0.07,35289998,0.012,PGX_AM_BS_17952124-cig-25,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.999000,,,,,,,,,0,57.75,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad797,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv7h,pgxind-kftx2o7q,pgxcs-kftvpyir,242198141,0.084,103095911,0.036,139102230,0.048,PGX_AM_BS_17952124-cig-26,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:22.002000,,,,,,,,,0,45.5,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad77e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,geo:GSE8398,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6c,pgxind-kftx2o6c,pgxcs-kftvpy6q,552546036,0.192,224618789,0.078,327927247,0.114,PGX_AM_BS_17952124-cig-24,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.967000,,,,,,,,,1,11,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad77f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,geo:GSE8398,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6e,pgxind-kftx2o6e,pgxcs-kftvpy77,152933543,0.053,152923874,0.053,9669,0,PGX_AM_BS_17952124-cig-02,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.968000,,,,,,,,,1,26.25,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad781,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6h,pgxind-kftx2o6i,pgxcs-kftvpy85,194705435,0.068,194409230,0.068,296205,0,PGX_AM_BS_17952124-cig-04,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.971000,,,,,,,,,1,21,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c6727983b2e00ad782,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6j,pgxind-kftx2o6k,pgxcs-kftvpy8n,147974525,0.051,45695507,0.016,102279018,0.036,PGX_AM_BS_17952124-cig-05,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.972000,,,,,,,,,1,12,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad784,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,geo:GSE8398,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv6m,pgxind-kftx2o6o,pgxcs-kftvpy9l,587890987,0.204,46979200,0.016,540911787,0.188,PGX_AM_BS_17952124-cig-07,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.975000,,,,,,,,,1,28,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad78f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv74,pgxind-kftx2o7a,pgxcs-kftvpyev,334735476,0.116,140625405,0.049,194110071,0.068,PGX_AM_BS_17952124-cig-19,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.990000,,,,,,,,,1,17.25,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad792,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,geo:GSE8398,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv79,pgxind-kftx2o7g,pgxcs-kftvpygc,357641178,0.124,333029843,0.116,24611335,0.009,PGX_AM_BS_17952124-cig-22,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.995000,,,,,,,,,1,23.25,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c6727983b2e00ad793,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgv7a,pgxind-kftx2o7i,pgxcs-kftvpygt,527974854,0.184,96221419,0.033,431753435,0.15,PGX_AM_BS_17952124-cig-23,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:21.996000,,,,,,,,,1,26.5,geo:GSE8398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5dc17fd509d374f6dd7ed867,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Ewing sarcoma,geo:GSE8398,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C40.0,bones and joints,pgxbs-kftvk114,pgxind-kftx60rf,pgxcs-kftwo319,126302,0,116633,0,9669,0,PGX_AM_BS_GSM207893,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:46:28.087000,,,,,,,,,1,26.25,geo:GPL2879,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,geo:gse,geo:gpl,pubmed,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,geo:gsm,geo:GSM207893,,arraymap import,,,,,,,,,,,,,,,,,M
5dc17fd509d374f6dd7ed876,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Ewing sarcoma,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C40.0,bones and joints,pgxbs-kftvk117,pgxind-kftx60rj,pgxcs-kftwo31w,41625242,0.014,41615573,0.014,9669,0,PGX_AM_BS_GSM207895,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:46:28.089000,,,,,,,,,1,21,geo:GSE8398,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,pubmed,geo:gse,geo:gpl,geo:GPL2879,,,,,,geo:gsm,geo:GSM207895,,arraymap import,,,,,,,,,,,,,,,,,M
5dc17fd509d374f6dd7ed87b,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Ewing sarcoma,geo:GSM207896,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C40.0,bones and joints,pgxbs-kftvk119,pgxind-kftx60rl,pgxcs-kftwo327,0,0,0,0,0,0,PGX_AM_BS_GSM207896,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:46:28.090000,,,,,,,,,1,12,geo:GSE8398,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,geo:gsm,geo:gse,geo:gpl,geo:GPL2879,,,,,,pubmed,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",arraymap import,,,,,,,,,,,,,,,,,F
5dc17fd609d374f6dd7ed881,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Ewing sarcoma,geo:GSE8398,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C40.0,bones and joints,pgxbs-kftvk11c,pgxind-kftx60rp,pgxcs-kftwo32t,44313895,0.015,44313895,0.015,0,0,PGX_AM_BS_GSM207898,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:46:28.092000,,,,,,,,,1,28,geo:GPL2879,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,geo:gse,geo:gpl,pubmed,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,geo:gsm,geo:GSM207898,,arraymap import,,,,,,,,,,,,,,,,,F
5dc17fd809d374f6dd7ed8da,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Ewing sarcoma,geo:GSE8398,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C40.0,bones and joints,pgxbs-kftvk11u,pgxind-kftx60sc,pgxcs-kftwo36a,133745837,0.047,133745837,0.047,0,0,PGX_AM_BS_GSM207909,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:46:28.104000,,,,,,,,,1,17.25,geo:GPL2879,,pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,geo:gse,geo:gpl,pubmed,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,geo:gsm,geo:GSM207909,,arraymap import,,,,,,,,,,,,,,,,,F
5dc17fd909d374f6dd7ed8f2,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Ewing sarcoma,geo:GSM207912,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C40.0,bones and joints,pgxbs-kftvk11z,pgxind-kftx60si,pgxcs-kftwo377,176557471,0.061,169985612,0.059,6571859,0.002,PGX_AM_BS_GSM207912,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:46:28.107000,,,,,,,,,1,23.25,geo:GPL2879,,pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,geo:gsm,geo:gpl,geo:gse,geo:GSE8398,,,,,,pubmed,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",arraymap import,,,,,,,,,,,,,,,,,F
5dc17fd909d374f6dd7ed9a1,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Ewing sarcoma,geo:GSM207913,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C40.0,bones and joints,pgxbs-kftvk121,pgxind-kftx60sk,pgxcs-kftwo37i,33741056,0.012,26975551,0.009,6765505,0.002,PGX_AM_BS_GSM207913,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:46:28.108000,,,,,,,,,1,26.5,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",pgxcohort-2021progenetix,Version at Progenetix Update 2021,,,geo:gsm,pubmed,geo:gpl,geo:GPL2879,,,,,,geo:gse,geo:GSE8398,,arraymap import,,,,,,,,,,,,,,,,,F
5dc17fd909d374f6dd7eda44,pgxcohort-arraymap,arrayMap collection,DUO:0000004,no restriction,Ewing sarcoma,geo:GSM207914,,NCIT:C4817,Ewing Sarcoma,icdom-92603,Ewing sarcoma,icdot-C40.0,bones and joints,pgxbs-kftvk122,pgxind-kftx60sm,pgxcs-kftwo37t,187246037,0.065,179252008,0.062,7994029,0.003,PGX_AM_BS_GSM207914,{},-3.7,40.42,Point,ESP,Madrid,Spain,"Madrid, Spain",40.42,-3.7,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:46:28.109000,,,,,,,,,1,11,PMID:17952124,"Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",pgxcohort-gao2021signatures,Gao and Baudis - Cancer CNV Signatures (2021),pgxcohort-2021progenetix,Version at Progenetix Update 2021,geo:gsm,pubmed,geo:gpl,geo:GPL2879,,,,,,geo:gse,geo:GSE8398,,arraymap import,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae21e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Lower leg, subcutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgywp,pgxind-kftx2sfh,pgxcs-kftvr0b4,747336584,0.26,460527249,0.16,286809335,0.1,PGX_AM_BS_16938566_LMS-lar-01,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.739000,P44Y,,,,,,,,0,138.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae21f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Head and neck, cutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgywr,pgxind-kftx2sfj,pgxcs-kftvr0bm,322306301,0.112,116600117,0.041,205706184,0.072,PGX_AM_BS_16938566_LMS-lar-02,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.740000,P36Y,,,,,,,,0,182.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae220,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Foot, subcutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgyws,pgxind-kftx2sfl,pgxcs-kftvr0c3,1197454304,0.417,758015693,0.264,439438611,0.153,PGX_AM_BS_16938566_LMS-lar-03,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.742000,P64Y,,,,,,,,0,77.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae221,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Upper trunk, cutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgywu,pgxind-kftx2sfn,pgxcs-kftvr0ck,519905917,0.181,472205870,0.164,47700047,0.017,PGX_AM_BS_16938566_LMS-lar-04,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.743000,P57Y,,,,,,,,0,97.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae223,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Upper arm, cutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgywx,pgxind-kftx2sfr,pgxcs-kftvr0di,498863212,0.174,498863212,0.174,0,0,PGX_AM_BS_16938566_LMS-lar-06,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.746000,P25Y,,,,,,,,0,182.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae224,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Upper trunk, cutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgywz,pgxind-kftx2sft,pgxcs-kftvr0dz,202970438,0.071,202970438,0.071,0,0,PGX_AM_BS_16938566_LMS-lar-07,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.748000,P65Y,,,,,,,,0,30.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae226,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, deep]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgyx2,pgxind-kftx2sfx,pgxcs-kftvr0ey,1035413741,0.36,362307646,0.126,673106095,0.234,PGX_AM_BS_16938566_LMS-lar-09,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.750000,P61Y,,,,,,,,0,211.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae227,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, cutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgyx4,pgxind-kftx2sfz,pgxcs-kftvr0ff,911611248,0.317,619503455,0.215,292107793,0.102,PGX_AM_BS_16938566_LMS-lar-10,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.752000,P46Y,,,,,,,,0,49.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae454,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzm7,pgxind-kftx2tat,pgxcs-kftvr85q,0,0,0,0,0,0,PGX_AM_BS_LMS-sva-01,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.907000,P20Y,,,,,,,,0,104.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae455,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzm9,pgxind-kftx2tav,pgxcs-kftvr868,519905917,0.181,472205870,0.164,47700047,0.017,PGX_AM_BS_LMS-sva-02,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.908000,P57Y,,,,,,,,0,97.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae456,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmb,pgxind-kftx2tax,pgxcs-kftvr86p,322306301,0.112,116600117,0.041,205706184,0.072,PGX_AM_BS_LMS-sva-03,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.909000,P36Y,,,,,,,,0,182.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae458,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzme,pgxind-kftx2tb1,pgxcs-kftvr89l,1197454304,0.417,758015693,0.264,439438611,0.153,PGX_AM_BS_LMS-sva-05,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.912000,P64Y,,,,,,,,0,77.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae459,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmf,pgxind-kftx2tb3,pgxcs-kftvr8a3,747336584,0.26,460527249,0.16,286809335,0.1,PGX_AM_BS_LMS-sva-06,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.914000,P44Y,,,,,,,,0,138.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae45b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmj,pgxind-kftx2tb7,pgxcs-kftvr8b2,498863212,0.174,498863212,0.174,0,0,PGX_AM_BS_LMS-sva-08,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.917000,P25Y,,,,,,,,0,182.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae45c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzml,pgxind-kftx2tb9,pgxcs-kftvr8bj,202970438,0.071,202970438,0.071,0,0,PGX_AM_BS_LMS-sva-09,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.918000,P65Y,,,,,,,,0,30.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae45d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmm,pgxind-kftx2tbb,pgxcs-kftvr8c1,820074047,0.285,412414969,0.143,407659078,0.142,PGX_AM_BS_LMS-sva-10,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.919000,P55Y,,,,,,,,0,137.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae45f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmq,pgxind-kftx2tbf,pgxcs-kftvr8cz,911611248,0.317,619503455,0.215,292107793,0.102,PGX_AM_BS_LMS-sva-12,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.922000,P46Y,,,,,,,,0,49.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae461,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmt,pgxind-kftx2tbj,pgxcs-kftvr8dy,859969166,0.299,472768129,0.164,387201037,0.135,PGX_AM_BS_LMS-sva-14,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.925000,P59Y,,,,,,,,0,193.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae462,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmv,pgxind-kftx2tbl,pgxcs-kftvr8eg,491264897,0.171,298869988,0.104,192394909,0.067,PGX_AM_BS_LMS-sva-15,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.926000,P49Y,,,,,,,,0,68.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae463,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmw,pgxind-kftx2tbn,pgxcs-kftvr8ex,1211003198,0.421,582834380,0.203,628168818,0.218,PGX_AM_BS_LMS-sva-16,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.928000,P62Y,,,,,,,,0,159.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae465,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmz,pgxind-kftx2tbr,pgxcs-kftvr8fx,1035413741,0.36,362307646,0.126,673106095,0.234,PGX_AM_BS_LMS-sva-18,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.930000,P61Y,,,,,,,,0,211.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae46d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgznc,pgxind-kftx2tc7,pgxcs-kftvr8jt,1040532638,0.362,551134841,0.192,489397797,0.17,PGX_AM_BS_LMS-sva-26,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.941000,P70Y,,,,,,,,0,55.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae472,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgznk,pgxind-kftx2tci,pgxcs-kftvr8m7,841827226,0.293,54300054,0.019,787527172,0.274,PGX_AM_BS_LMS-sva-31,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.948000,P55Y,,,,,,,,0,174.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae7bf,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,leiomyosarcoma [grade 1-2],PMID:16080954,"Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh0pt,pgxind-kftx2uo5,pgxcs-kftvrkij,666969600,0.232,460481037,0.16,206488563,0.072,PGX_AM_BS_AEB-16080954-2,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:28.129000,P57Y,,,,,,,,0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae7c0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,leiomyosarcoma [grade 3],PMID:16080954,"Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh0pu,pgxind-kftx2uo7,pgxcs-kftvrkj0,140923879,0.049,95413850,0.033,45510029,0.016,PGX_AM_BS_AEB-16080954-3,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:28.130000,P50Y,,,,,,NCITgrade-C28079,Grade 3,0,48,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae7c1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,leiomyosarcoma [grade 3],PMID:16080954,"Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh0pw,pgxind-kftx2uo9,pgxcs-kftvrkji,113313868,0.039,78913834,0.027,34400034,0.012,PGX_AM_BS_AEB-16080954-4,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:28.132000,P62Y,,,,,,NCITgrade-C28079,Grade 3,0,31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae7c3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,leiomyosarcoma [grade 3],PMID:16080954,"Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh0pz,pgxind-kftx2uod,pgxcs-kftvrkm1,848536129,0.295,515596882,0.179,332939247,0.116,PGX_AM_BS_AEB-16080954-6,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:28.135000,P46Y,,,,,,NCITgrade-C28079,Grade 3,0,60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae7c6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,leiomyosarcoma [grade 3],PMID:16080954,"Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh0q4,pgxind-kftx2uoj,pgxcs-kftvrknh,525735000,0.183,0,0,525735000,0.183,PGX_AM_BS_AEB-16080954-9,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:28.139000,P65Y,,,,,,NCITgrade-C28079,Grade 3,0,38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7ee,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Retroperitoneum, grade 3, --]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wf,pgxind-kftx315d,pgxcs-kftvt6dq,283114838,0.098,190214746,0.066,92900092,0.032,PGX_AM_BS_LMS-A3,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.869000,P83Y,,,,,,NCITgrade-C28079,Grade 3,0,84,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7f3,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, grade 2, ANED]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wn,pgxind-kftx315n,pgxcs-kftvt6g5,963643041,0.335,810432905,0.282,153210136,0.053,PGX_AM_BS_LMS-STS206,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.876000,P84Y,,,,,,NCITgrade-C28078,Grade 2,0,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7f5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Shoulder, grade 1, AWD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wq,pgxind-kftx315r,pgxcs-kftvt6h4,258666398,0.09,236466376,0.082,22200022,0.008,PGX_AM_BS_LMS-STS245,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.879000,P36Y,,,,,,NCITgrade-C28077,Grade 1,0,84.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7f8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Buttock, grade 2, AWD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wv,pgxind-kftx315w,pgxcs-kftvt6ik,435464799,0.151,235550043,0.082,199914756,0.07,PGX_AM_BS_LMS-STS326,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.883000,P67Y,,,,,,NCITgrade-C28078,Grade 2,0,71.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7fc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Groin, grade 2, ANED]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5x2,pgxind-kftx3164,pgxcs-kftvt6kh,567081991,0.197,242306221,0.084,324775770,0.113,PGX_AM_BS_LMS-STS398,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.889000,P55Y,,,,,,NCITgrade-C28078,Grade 2,0,90.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7fe,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, grade 2, AWD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5x5,pgxind-kftx3168,pgxcs-kftvt6lg,918333384,0.319,16100016,0.006,902233368,0.314,PGX_AM_BS_LMS-STS438,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.892000,P69Y,,,,,,NCITgrade-C28078,Grade 2,0,33.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af800,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Upper arm, grade 2, AWD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5x8,pgxind-kftx316b,pgxcs-kftvt6mf,998539709,0.347,554313991,0.193,444225718,0.155,PGX_AM_BS_LMS-STS448,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.895000,P50Y,,,,,,NCITgrade-C28078,Grade 2,0,117.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af802,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Intraperitoneum, grade 2, ANED]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5xb,pgxind-kftx316f,pgxcs-kftvt6ne,251140655,0.087,98143080,0.034,152997575,0.053,PGX_AM_BS_LMS-STS568,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.897000,P40Y,,,,,,NCITgrade-C28078,Grade 2,0,42.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af803,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Post Abdo, grade 2, AWD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5xd,pgxind-kftx316h,pgxcs-kftvt6nw,404867346,0.141,139514696,0.049,265352650,0.092,PGX_AM_BS_LMS-STS572,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.899000,P58Y,,,,,,NCITgrade-C28078,Grade 2,0,15.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af804,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, grade 3, ANED]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5xf,pgxind-kftx316j,pgxcs-kftvt6od,346114098,0.12,91700091,0.032,254414007,0.088,PGX_AM_BS_LMS-STS574,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.900000,P73Y,,,,,,NCITgrade-C28079,Grade 3,0,16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af805,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Groin, grade 3, AWD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5xg,pgxind-kftx316l,pgxcs-kftvt6ou,1062853376,0.37,664757303,0.231,398096073,0.138,PGX_AM_BS_LMS-STS576,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.901000,P23Y,,,,,,NCITgrade-C28079,Grade 3,0,37.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af806,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, grade 3, ANED]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5xi,pgxind-kftx316n,pgxcs-kftvt6pb,268792970,0.093,98143080,0.034,170649890,0.059,PGX_AM_BS_LMS-STS580,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.903000,P39Y,,,,,,NCITgrade-C28079,Grade 3,0,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af808,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Leg, grade 3, ANED]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5xl,pgxind-kftx316r,pgxcs-kftvt6qa,462056972,0.161,190214746,0.066,271842226,0.095,PGX_AM_BS_LMS-STS594,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.905000,P85Y,,,,,,NCITgrade-C28079,Grade 3,0,28.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae222,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Upper trunk, cutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgyww,pgxind-kftx2sfp,pgxcs-kftvr0d1,510436753,0.178,384368041,0.134,126068712,0.044,PGX_AM_BS_16938566_LMS-lar-05,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.745000,P78Y,,,,,,,,1,29.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae225,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Hand, subcutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgyx1,pgxind-kftx2sfv,pgxcs-kftvr0eg,1066993592,0.371,751023957,0.261,315969635,0.11,PGX_AM_BS_16938566_LMS-lar-08,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.749000,P80Y,,,,,,,,1,72.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae228,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, subcutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgyx6,pgxind-kftx2sg1,pgxcs-kftvr0fx,1343523094,0.467,1089373700,0.379,254149394,0.088,PGX_AM_BS_16938566_LMS-lar-11,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.753000,P91Y,,,,,,,,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae229,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, subcutaneous]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgyx7,pgxind-kftx2sg3,pgxcs-kftvr0ge,734744880,0.256,553806062,0.193,180938818,0.063,PGX_AM_BS_16938566_LMS-lar-12,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.755000,P55Y,,,,,,,,1,135.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae22a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Upper trunk, deep]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgyx9,pgxind-kftx2sg5,pgxcs-kftvr0gv,507828235,0.177,0,0,507828235,0.177,PGX_AM_BS_16938566_LMS-lar-13,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.756000,P77Y,,,,,,,,1,7.57,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae22b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Lower leg, deep]",PMID:16938566,"Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgyxa,pgxind-kftx2sg7,pgxcs-kftvr0hc,566076857,0.197,60238697,0.021,505838160,0.176,PGX_AM_BS_16938566_LMS-lar-14,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.758000,P35Y,,,,,,,,1,11.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae457,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmc,pgxind-kftx2taz,pgxcs-kftvr891,0,0,0,0,0,0,PGX_AM_BS_LMS-sva-04,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.911000,P37Y,,,,,,,,1,204.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae45a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmh,pgxind-kftx2tb5,pgxcs-kftvr8al,510436753,0.178,384368041,0.134,126068712,0.044,PGX_AM_BS_LMS-sva-07,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.915000,P78Y,,,,,,,,1,29.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae45e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmo,pgxind-kftx2tbd,pgxcs-kftvr8ci,521479613,0.181,296777849,0.103,224701764,0.078,PGX_AM_BS_LMS-sva-11,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.921000,P85Y,,,,,,,,1,42,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae460,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmr,pgxind-kftx2tbh,pgxcs-kftvr8dh,1055501325,0.367,500201152,0.174,555300173,0.193,PGX_AM_BS_LMS-sva-13,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.924000,P55Y,,,,,,,,1,70.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae464,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzmy,pgxind-kftx2tbp,pgxcs-kftvr8ff,1066993592,0.371,751023957,0.261,315969635,0.11,PGX_AM_BS_LMS-sva-17,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.929000,P80Y,,,,,,,,1,72.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae466,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzn1,pgxind-kftx2tbt,pgxcs-kftvr8ge,292985556,0.102,0,0,292985556,0.102,PGX_AM_BS_LMS-sva-19,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.932000,P56Y,,,,,,,,1,64.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae467,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzn3,pgxind-kftx2tbv,pgxcs-kftvr8gw,1354823105,0.471,1089373700,0.379,265449405,0.092,PGX_AM_BS_LMS-sva-20,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.933000,P91Y,,,,,,,,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae468,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzn4,pgxind-kftx2tbx,pgxcs-kftvr8hd,809198499,0.281,525812014,0.183,283386485,0.099,PGX_AM_BS_LMS-sva-21,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.934000,P79Y,,,,,,,,1,28.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae469,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzn6,pgxind-kftx2tbz,pgxcs-kftvr8hv,788193984,0.274,411758430,0.143,376435554,0.131,PGX_AM_BS_LMS-sva-22,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.936000,P71Y,,,,,,,,1,130.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae46a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzn8,pgxind-kftx2tc1,pgxcs-kftvr8ic,349000348,0.121,0,0,349000348,0.121,PGX_AM_BS_LMS-sva-23,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.937000,P75Y,,,,,,,,1,7.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae46b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzn9,pgxind-kftx2tc3,pgxcs-kftvr8iu,734744880,0.256,553806062,0.193,180938818,0.063,PGX_AM_BS_LMS-sva-24,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.939000,P55Y,,,,,,,,1,135.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae46c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgznb,pgxind-kftx2tc5,pgxcs-kftvr8jb,1108991426,0.386,530902914,0.185,578088512,0.201,PGX_AM_BS_LMS-sva-25,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.940000,P74Y,,,,,,,,1,31.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae46e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzne,pgxind-kftx2tc9,pgxcs-kftvr8ka,507828235,0.177,0,0,507828235,0.177,PGX_AM_BS_LMS-sva-27,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.943000,P77Y,,,,,,,,1,7.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae46f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgzng,pgxind-kftx2tcb,pgxcs-kftvr8kr,505838160,0.176,0,0,505838160,0.176,PGX_AM_BS_LMS-sva-28,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.944000,P35Y,,,,,,,,1,11.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae470,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgznh,pgxind-kftx2tcd,pgxcs-kftvr8l9,499312420,0.174,381543717,0.133,117768703,0.041,PGX_AM_BS_LMS-sva-29,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.945000,P58Y,,,,,,,,1,59.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae471,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgznj,pgxind-kftx2tcg,pgxcs-kftvr8lq,143827397,0.05,90927345,0.032,52900052,0.018,PGX_AM_BS_LMS-sva-30,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.947000,P60Y,,,,,,,,1,70.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae473,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgznm,pgxind-kftx2tck,pgxcs-kftvr8mp,526615032,0.183,149943131,0.052,376671901,0.131,PGX_AM_BS_LMS-sva-32,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.950000,P84Y,,,,,,,,1,10.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae7b7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,leiomyosarcoma [grade 3],PMID:16080954,"Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh0pg,pgxind-kftx2uno,pgxcs-kftvrkep,514946562,0.179,471771776,0.164,43174786,0.015,PGX_AM_BS_AEB-16080954-11,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:28.117000,P49Y,,,,,,NCITgrade-C28079,Grade 3,1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae7b9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,leiomyosarcoma [grade 3],PMID:16080954,"Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh0pj,pgxind-kftx2uns,pgxcs-kftvrkfo,521246343,0.181,145693674,0.051,375552669,0.131,PGX_AM_BS_AEB-16080954-13a,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:28.120000,P75Y,,,,,,NCITgrade-C28079,Grade 3,1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae7bb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,leiomyosarcoma [grade 2],PMID:16080954,"Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh0pm,pgxind-kftx2unw,pgxcs-kftvrkgm,0,0,0,0,0,0,PGX_AM_BS_AEB-16080954-14,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:28.123000,P76Y,,,,,,NCITgrade-C28078,Grade 2,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae7bc,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,leiomyosarcoma [grade 3],PMID:16080954,"Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh0po,pgxind-kftx2uny,pgxcs-kftvrkh3,706824251,0.246,378755339,0.132,328068912,0.114,PGX_AM_BS_AEB-16080954-15,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:28.125000,P47Y,,,,,,NCITgrade-C28079,Grade 3,1,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c8727983b2e00ae7c5,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,leiomyosarcoma [grade 3],PMID:16080954,"Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh0q2,pgxind-kftx2uoh,pgxcs-kftvrkn0,0,0,0,0,0,0,PGX_AM_BS_AEB-16080954-8,{},-80,40.44,Point,USA,Pittsburgh,United States of America,"Pittsburgh, United States",40.44,-80,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:28.137000,P53Y,,,,,,NCITgrade-C28079,Grade 3,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7ef,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, grade --, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wh,pgxind-kftx315f,pgxcs-kftvt6e8,653089345,0.227,190214746,0.066,462874599,0.161,PGX_AM_BS_LMS-A4,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:33.871000,P46Y,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7f0,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Buttock, grade 3, ]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wi,pgxind-kftx315h,pgxcs-kftvt6ep,472086155,0.164,0,0,472086155,0.164,PGX_AM_BS_LMS-A5,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.872000,P84Y,,,,,,NCITgrade-C28079,Grade 3,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7f1,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Retro abdo, grade 2, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wk,pgxind-kftx315j,pgxcs-kftvt6f7,699695187,0.243,516709505,0.18,182985682,0.064,PGX_AM_BS_LMS-STS158,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.873000,P53Y,,,,,,NCITgrade-C28078,Grade 2,1,18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7f2,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, grade 3, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wm,pgxind-kftx315l,pgxcs-kftvt6fo,912805508,0.317,401950668,0.14,510854840,0.178,PGX_AM_BS_LMS-STS194,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.875000,P74Y,,,,,,NCITgrade-C28079,Grade 3,1,11.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7f4,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Upper arm, grade 2, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wp,pgxind-kftx315p,pgxcs-kftvt6gn,654230460,0.228,237657776,0.083,416572684,0.145,PGX_AM_BS_LMS-STS218,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.878000,P66Y,,,,,,NCITgrade-C28078,Grade 2,1,29.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7f6,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Intra abdo, grade 3, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5ws,pgxind-kftx315s,pgxcs-kftvt6hl,421206877,0.147,253056989,0.088,168149888,0.058,PGX_AM_BS_LMS-STS255,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.881000,P53Y,,,,,,NCITgrade-C28079,Grade 3,1,27.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7f7,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Retro abdo, grade 3, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wu,pgxind-kftx315u,pgxcs-kftvt6i2,340413722,0.118,133158000,0.046,207255722,0.072,PGX_AM_BS_LMS-STS323,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.882000,P58Y,,,,,,NCITgrade-C28079,Grade 3,1,78.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7f9,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Retro abdo, grade 2, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wx,pgxind-kftx315y,pgxcs-kftvt6j1,930315317,0.324,854198087,0.297,76117230,0.026,PGX_AM_BS_LMS-STS379,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.885000,P17Y,,,,,,NCITgrade-C28078,Grade 2,1,33.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7fa,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Buttock, grade 2, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5wy,pgxind-kftx3160,pgxcs-kftvt6ji,1198099828,0.417,158160294,0.055,1039939534,0.362,PGX_AM_BS_LMS-STS388,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.886000,P73Y,,,,,,NCITgrade-C28078,Grade 2,1,7.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7fb,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, grade 3, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5x0,pgxind-kftx3162,pgxcs-kftvt6jz,306144130,0.106,95413850,0.033,210730280,0.073,PGX_AM_BS_LMS-STS389,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.888000,P76Y,,,,,,NCITgrade-C28079,Grade 3,1,19.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af7fd,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Buttock, grade 3, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5x3,pgxind-kftx3166,pgxcs-kftvt6ky,743267133,0.259,547089819,0.19,196177314,0.068,PGX_AM_BS_LMS-STS411,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.890000,P72Y,,,,,,NCITgrade-C28079,Grade 3,1,25.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af7ff,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Retro abdo, grade 2, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5x7,pgxind-kftx316a,pgxcs-kftvt6ly,703376047,0.245,412951480,0.144,290424567,0.101,PGX_AM_BS_LMS-STS441,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.893000,P63Y,,,,,,NCITgrade-C28078,Grade 2,1,44.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af801,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Thigh, grade 3, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5xa,pgxind-kftx316d,pgxcs-kftvt6mx,800001976,0.278,366493156,0.127,433508820,0.151,PGX_AM_BS_LMS-STS550,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.896000,P72Y,,,,,,NCITgrade-C28079,Grade 3,1,11.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56ca727983b2e00af807,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Retro Pelvis, grade 2, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5xk,pgxind-kftx316p,pgxcs-kftvt6pt,633958516,0.221,190214746,0.066,443743770,0.154,PGX_AM_BS_LMS-STS587,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,,2020-09-10 17:44:33.904000,P67Y,,,,,,NCITgrade-C28078,Grade 2,1,2.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56ca727983b2e00af809,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Leiomyosarcoma [Intraperitoneum, grade --, DOD]",PMID:12920222,"Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...",NCIT:C3158,Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvh5xn,pgxind-kftx316t,pgxcs-kftvt6qr,792020787,0.275,350382689,0.122,441638098,0.154,PGX_AM_BS_LMS-STS91,{},-0.2,51.35,Point,GBR,Sutton,United Kingdom,"Sutton, United Kingdom",51.35,-0.2,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:33.907000,P64Y,,,,,,,,1,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac253,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Retroperitoneum],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgodw,pgxind-kftx2fou,pgxcs-kftvnur2,0,0,0,0,0,0,PGX_AM_BS_20159821_MPNST-bre-023,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.486000,P64Y,,,,,,,,0,116,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac254,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgodx,pgxind-kftx2fow,pgxcs-kftvnuri,1937835042,0.674,951076918,0.331,986758124,0.343,PGX_AM_BS_20159821_MPNST-bre-024,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.487000,P41Y,,,,,,,,0,122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac258,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe4,pgxind-kftx2fp4,pgxcs-kftvnutf,0,0,0,0,0,0,PGX_AM_BS_20159821_MPNST-bre-034,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.493000,P15Y,,,,,,,,0,138,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac25c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoea,pgxind-kftx2fpc,pgxcs-kftvnuvc,1009805081,0.351,120236424,0.042,889568657,0.309,PGX_AM_BS_20159821_MPNST-bre-040,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.498000,P50Y,,,,,,,,0,122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac25d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lower trunk]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoec,pgxind-kftx2fpe,pgxcs-kftvnuvs,1163881456,0.405,586567547,0.204,577313909,0.201,PGX_AM_BS_20159821_MPNST-bre-043,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.500000,P14Y,,,,,,,,0,105,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac25f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Knee]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoef,pgxind-kftx2fpi,pgxcs-kftvnuwr,532438858,0.185,390043997,0.136,142394861,0.05,PGX_AM_BS_20159821_MPNST-bre-046,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.503000,P45Y,,,,,,,,0,125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac261,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoej,pgxind-kftx2fpm,pgxcs-kftvnuxp,217731742,0.076,201431726,0.07,16300016,0.006,PGX_AM_BS_20159821_MPNST-bre-049,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.505000,P27Y,,,,,,,,0,46,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac262,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Leg],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoek,pgxind-kftx2fpo,pgxcs-kftvnuy6,1254288828,0.436,423375067,0.147,830913761,0.289,PGX_AM_BS_20159821_MPNST-bre-050,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.507000,P30Y,,,,,,,,0,133,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac266,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoer,pgxind-kftx2fpw,pgxcs-kftvnv02,1491366828,0.519,825593611,0.287,665773217,0.232,PGX_AM_BS_20159821_MPNST-bre-056,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.513000,P24Y,,,,,,,,0,185,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac269,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Shoulder]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoew,pgxind-kftx2fq2,pgxcs-kftvnv1h,835898392,0.291,609102445,0.212,226795947,0.079,PGX_AM_BS_20159821_MPNST-bre-060,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.517000,P20Y,,,,,,,,0,369,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac26a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Under arm],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoex,pgxind-kftx2fq4,pgxcs-kftvnv1y,1099256834,0.382,876843898,0.305,222412936,0.077,PGX_AM_BS_20159821_MPNST-bre-061,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.519000,P59Y,,,,,,,,0,142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac277,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Axilla],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofi,pgxind-kftx2fqu,pgxcs-kftvnv84,1267780766,0.441,194785694,0.068,1072995072,0.373,PGX_AM_BS_20159821_MPNST-bre-087,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.538000,P40Y,,,,,,,,0,168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac27c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofq,pgxind-kftx2fr4,pgxcs-kftvnvai,198170501,0.069,121195682,0.042,76974819,0.027,PGX_AM_BS_20159821_MPNST-bre-116,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.545000,P30Y,,,,,,,,0,87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac250,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Upper trunk]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgodq,pgxind-kftx2foo,pgxcs-kftvnupl,1329127181,0.462,307514884,0.107,1021612297,0.355,PGX_AM_BS_20159821_MPNST-bre-013,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.481000,P26Y,,,,,,,,1,79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac251,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgods,pgxind-kftx2foq,pgxcs-kftvnuq2,0,0,0,0,0,0,PGX_AM_BS_20159821_MPNST-bre-020,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.483000,P19Y,,,,,,,,1,186,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac252,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgodu,pgxind-kftx2fos,pgxcs-kftvnuqj,1636953920,0.569,725961202,0.253,910992718,0.317,PGX_AM_BS_20159821_MPNST-bre-021,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.484000,P18Y,,,,,,,,1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac255,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgodz,pgxind-kftx2foy,pgxcs-kftvnus0,1165492623,0.405,135327390,0.047,1030165233,0.358,PGX_AM_BS_20159821_MPNST-bre-026,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.489000,P22Y,,,,,,,,1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac256,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lower trunk]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe0,pgxind-kftx2fp0,pgxcs-kftvnusg,2763479032,0.961,1140622209,0.397,1622856823,0.564,PGX_AM_BS_20159821_MPNST-bre-029,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.490000,P33Y,,,,,,,,1,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac257,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Buttock],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe2,pgxind-kftx2fp2,pgxcs-kftvnusy,1104109901,0.384,446385191,0.155,657724710,0.229,PGX_AM_BS_20159821_MPNST-bre-032,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.492000,P77Y,,,,,,,,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac259,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Pelvis],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe5,pgxind-kftx2fp5,pgxcs-kftvnutw,1851316984,0.644,604400129,0.21,1246916855,0.434,PGX_AM_BS_20159821_MPNST-bre-035,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.494000,P42Y,,,,,,,,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac25a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe7,pgxind-kftx2fp8,pgxcs-kftvnuud,2832113038,0.985,1257209528,0.437,1574903510,0.548,PGX_AM_BS_20159821_MPNST-bre-037,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.496000,P34Y,,,,,,,,1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac25b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Upper trunk]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoe9,pgxind-kftx2fpa,pgxcs-kftvnuuu,197338834,0.069,12600013,0.004,184738821,0.064,PGX_AM_BS_20159821_MPNST-bre-038,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.497000,P71Y,,,,,,,,1,100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac25e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoee,pgxind-kftx2fpg,pgxcs-kftvnuwa,2617449835,0.91,989113185,0.344,1628336650,0.566,PGX_AM_BS_20159821_MPNST-bre-044,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.501000,P17Y,,,,,,,,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac260,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoeh,pgxind-kftx2fpk,pgxcs-kftvnux8,1486291449,0.517,644670186,0.224,841621263,0.293,PGX_AM_BS_20159821_MPNST-bre-048,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.504000,P35Y,,,,,,,,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac263,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Buttock],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoem,pgxind-kftx2fpq,pgxcs-kftvnuyn,1984268799,0.69,489597598,0.17,1494671201,0.52,PGX_AM_BS_20159821_MPNST-bre-051,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.508000,P73Y,,,,,,,,1,8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac264,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Proximal arm],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoeo,pgxind-kftx2fps,pgxcs-kftvnuz4,863649586,0.3,659825104,0.23,203824482,0.071,PGX_AM_BS_20159821_MPNST-bre-052,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.510000,P37Y,,,,,,,,1,81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac265,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Pelvis]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoep,pgxind-kftx2fpu,pgxcs-kftvnuzl,811243086,0.282,494740890,0.172,316502196,0.11,PGX_AM_BS_20159821_MPNST-bre-053,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.511000,P15Y,,,,,,,,1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac267,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Intrathoracic]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoet,pgxind-kftx2fpy,pgxcs-kftvnv0j,1489346799,0.518,494635615,0.172,994711184,0.346,PGX_AM_BS_20159821_MPNST-bre-057,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.514000,P24Y,,,,,,,,1,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac26b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoez,pgxind-kftx2fq6,pgxcs-kftvnv2f,1323499107,0.46,471638913,0.164,851860194,0.296,PGX_AM_BS_20159821_MPNST-bre-063,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.520000,P62Y,,,,,,,,1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac26c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thoracic wall]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof1,pgxind-kftx2fq8,pgxcs-kftvnv2w,1437003163,0.5,557693347,0.194,879309816,0.306,PGX_AM_BS_20159821_MPNST-bre-064,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.522000,P26Y,,,,,,,,1,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac26d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Right shoulder]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof2,pgxind-kftx2fqa,pgxcs-kftvnv3e,1350313022,0.47,810871505,0.282,539441517,0.188,PGX_AM_BS_20159821_MPNST-bre-065,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.523000,P53Y,,,,,,,,1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac26e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lung]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof4,pgxind-kftx2fqc,pgxcs-kftvnv3v,1540858905,0.536,635641927,0.221,905216978,0.315,PGX_AM_BS_20159821_MPNST-bre-067,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.525000,P28Y,,,,,,,,1,118,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac26f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof6,pgxind-kftx2fqe,pgxcs-kftvnv4c,1407853388,0.49,769905657,0.268,637947731,0.222,PGX_AM_BS_20159821_MPNST-bre-068,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.526000,P41Y,,,,,,,,1,39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac270,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Mediastinum],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof7,pgxind-kftx2fqg,pgxcs-kftvnv4s,2510212230,0.873,1444256608,0.502,1065955622,0.371,PGX_AM_BS_20159821_MPNST-bre-070,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.528000,P73Y,,,,,,,,1,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac271,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Pelvis]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgof9,pgxind-kftx2fqi,pgxcs-kftvnv5a,366871444,0.128,183232624,0.064,183638820,0.064,PGX_AM_BS_20159821_MPNST-bre-074,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.529000,P29Y,,,,,,,,1,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac272,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lung]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofb,pgxind-kftx2fqk,pgxcs-kftvnv5r,248896417,0.087,90521516,0.031,158374901,0.055,PGX_AM_BS_20159821_MPNST-bre-077,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.531000,P26Y,,,,,,,,1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac273,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofc,pgxind-kftx2fqm,pgxcs-kftvnv68,0,0,0,0,0,0,PGX_AM_BS_20159821_MPNST-bre-079,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.532000,P21Y,,,,,,,,1,104,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac275,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Mediastinum]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgoff,pgxind-kftx2fqq,pgxcs-kftvnv76,1958473088,0.681,680007220,0.237,1278465868,0.445,PGX_AM_BS_20159821_MPNST-bre-083,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.535000,P52Y,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac276,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Neck]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofh,pgxind-kftx2fqs,pgxcs-kftvnv7n,2496649693,0.868,1151180206,0.4,1345469487,0.468,PGX_AM_BS_20159821_MPNST-bre-086,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.536000,P42Y,,,,,,,,1,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac278,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofk,pgxind-kftx2fqw,pgxcs-kftvnv8l,2312561261,0.804,946983195,0.329,1365578066,0.475,PGX_AM_BS_20159821_MPNST-bre-088,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.539000,P32Y,,,,,,,,1,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac27b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Back],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofp,pgxind-kftx2fr2,pgxcs-kftvnva1,196600196,0.068,196600196,0.068,0,0,PGX_AM_BS_20159821_MPNST-bre-115,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.544000,P54Y,,,,,,,,1,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac27d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofs,pgxind-kftx2fr6,pgxcs-kftvnvay,1099762116,0.383,128240240,0.045,971521876,0.338,PGX_AM_BS_20159821_MPNST-bre-117,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.547000,P79Y,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c3727983b2e00ac27e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Thigh],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofu,pgxind-kftx2fr8,pgxcs-kftvnvbf,93117817,0.032,61943043,0.022,31174774,0.011,PGX_AM_BS_20159821_MPNST-bre-118,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.548000,P11Y,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac27f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Lung],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgofv,pgxind-kftx2fra,pgxcs-kftvnvbw,479964775,0.167,187162556,0.065,292802219,0.102,PGX_AM_BS_20159821_MPNST-bre-120,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.550000,P32Y,,,,,,,,1,53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac28b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Neck]",PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgogf,pgxind-kftx2fry,pgxcs-kftvnvhj,1830651586,0.637,654808603,0.228,1175842983,0.409,PGX_AM_BS_20159821_MPNST-bre-080,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.566000,P25Y,,,,,,,,1,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c3727983b2e00ac290,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Malignant peripheral nerve sheath tumor [Buttock],PMID:20159821,"Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...",NCIT:C3798,Malignant Peripheral Nerve Sheath Tumor,icdom-95403,Malignant peripheral nerve sheath tumor,icdot-C47.9,peripheral nervs incl. autonomous,pgxbs-kftvgogn,pgxind-kftx2fs8,pgxcs-kftvnvjv,382244997,0.133,197906177,0.069,184338820,0.064,PGX_AM_BS_20159821_MPNST-bre-091,{},10.75,59.91,Point,NOR,Oslo,Norway,"Oslo, Norway",59.91,10.75,city,Feature,EFO:0009656,neoplastic sample,UBERON:0001780,spinal nerve,{},2020-09-10 17:44:14.573000,P45Y,,,,,,,,1,123,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd2c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal ulna, Primary, Fibroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7kw,pgxind-kftx338w,pgxcs-kftvtp6u,773488058,0.269,410144507,0.143,363343551,0.126,PGX_AM_BS_OstSarc-oza-02,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.718000,P17Y,,,,,,,,0,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd2d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Tibia, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7ky,pgxind-kftx338y,pgxcs-kftvtp7c,622773520,0.217,204249739,0.071,418523781,0.146,PGX_AM_BS_OstSarc-oza-03,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.720000,P6Y,,,,,,,,0,37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd2e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Humerus, Primary, Teleangiectatic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7l0,pgxind-kftx3390,pgxcs-kftvtp7u,330801085,0.115,87593618,0.03,243207467,0.085,PGX_AM_BS_OstSarc-oza-04,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.721000,P14Y,,,,,,,,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd2f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Tibia, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7l1,pgxind-kftx3392,pgxcs-kftvtp8b,1054055251,0.367,597432101,0.208,456623150,0.159,PGX_AM_BS_OstSarc-oza-05,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.722000,P15Y,,,,,,,,0,33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd31,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Femur, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7l4,pgxind-kftx3397,pgxcs-kftvtp9a,2258752815,0.786,688359004,0.239,1570393811,0.546,PGX_AM_BS_OstSarc-oza-07,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.725000,P19Y,,,,,,,,0,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd33,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Tibia, Primary, Fibroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7l8,pgxind-kftx339b,pgxcs-kftvtpa9,2082369258,0.724,980903263,0.341,1101465995,0.383,PGX_AM_BS_OstSarc-oza-09,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.728000,P21Y,,,,,,,,0,33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd34,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7l9,pgxind-kftx339d,pgxcs-kftvtpaq,1666218807,0.58,692786238,0.241,973432569,0.339,PGX_AM_BS_OstSarc-oza-10,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.729000,P13Y,,,,,,,,0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd35,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lb,pgxind-kftx339f,pgxcs-kftvtpb8,1501280965,0.522,742773633,0.258,758507332,0.264,PGX_AM_BS_OstSarc-oza-11,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.731000,P20Y,,,,,,,,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd36,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Femur, Primary, Osteoblastic1]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lc,pgxind-kftx339h,pgxcs-kftvtpbp,377589400,0.131,172297594,0.06,205291806,0.071,PGX_AM_BS_OstSarc-oza-12,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.732000,P16Y,,,,,,,,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd38,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lg,pgxind-kftx339l,pgxcs-kftvtpco,41600041,0.014,0,0,41600041,0.014,PGX_AM_BS_OstSarc-oza-14,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.735000,P33Y,,,,,,,,0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd39,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Radius, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lh,pgxind-kftx339n,pgxcs-kftvtpd5,1411384860,0.491,646939617,0.225,764445243,0.266,PGX_AM_BS_OstSarc-oza-15,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.736000,P24Y,,,,,,,,0,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd3b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary, Parosteal]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lk,pgxind-kftx339r,pgxcs-kftvtpe3,102900102,0.036,0,0,102900102,0.036,PGX_AM_BS_OstSarc-oza-17,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.739000,P15Y,,,,,,,,0,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd3c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lm,pgxind-kftx339t,pgxcs-kftvtpek,1100113249,0.383,553125104,0.192,546988145,0.19,PGX_AM_BS_OstSarc-oza-18,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.741000,P13Y,,,,,,,,0,28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd3d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary, Fibroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lo,pgxind-kftx339v,pgxcs-kftvtpf2,1320240031,0.459,721951079,0.251,598288952,0.208,PGX_AM_BS_OstSarc-oza-19,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.742000,P16Y,,,,,,,,0,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd3e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Humerus, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lp,pgxind-kftx339x,pgxcs-kftvtpfj,502402315,0.175,190952284,0.066,311450031,0.108,PGX_AM_BS_OstSarc-oza-20,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.744000,P28Y,,,,,,,,0,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd40,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary, Pstrosteal]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7ls,pgxind-kftx33a1,pgxcs-kftvtpgh,731396905,0.254,327043309,0.114,404353596,0.141,PGX_AM_BS_OstSarc-oza-22,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.746000,P29Y,,,,,,,,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd41,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lu,pgxind-kftx33a3,pgxcs-kftvtpgz,1223174437,0.425,355501627,0.124,867672810,0.302,PGX_AM_BS_OstSarc-oza-23,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.748000,P16Y,,,,,,,,0,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd42,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Tibia, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lw,pgxind-kftx33a5,pgxcs-kftvtphg,1087258264,0.378,667464584,0.232,419793680,0.146,PGX_AM_BS_OstSarc-oza-24,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.750000,P35Y,,,,,,,,0,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd43,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Tibia, Primary, Fibroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lx,pgxind-kftx33a7,pgxcs-kftvtphy,222538859,0.077,71300071,0.025,151238788,0.053,PGX_AM_BS_OstSarc-oza-25,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.751000,P17Y,,,,,,,,0,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd44,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Humerus, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lz,pgxind-kftx33a9,pgxcs-kftvtpif,1025257270,0.357,504682149,0.176,520575121,0.181,PGX_AM_BS_OstSarc-oza-26,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.752000,P16Y,,,,,,,,0,21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd45,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7m1,pgxind-kftx33ab,pgxcs-kftvtpiw,1066209058,0.371,305540977,0.106,760668081,0.265,PGX_AM_BS_OstSarc-oza-27,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.754000,P9Y,,,,,,,,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd46,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7m2,pgxind-kftx33ad,pgxcs-kftvtpje,1441051519,0.501,549761945,0.191,891289574,0.31,PGX_AM_BS_OstSarc-oza-28,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.755000,P34Y,,,,,,,,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd47,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Tibia, Primary, Periosteal-G3]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7m4,pgxind-kftx33af,pgxcs-kftvtpjv,0,0,0,0,0,0,PGX_AM_BS_OstSarc-oza-29,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.757000,P15Y,,,,,,,,0,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd48,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7m6,pgxind-kftx33ah,pgxcs-kftvtpkc,333706311,0.116,236006215,0.082,97700096,0.034,PGX_AM_BS_OstSarc-oza-30,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.758000,P12Y,,,,,,,,0,26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd49,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Humerus, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7m7,pgxind-kftx33aj,pgxcs-kftvtpku,1625674673,0.565,863740888,0.3,761933785,0.265,PGX_AM_BS_OstSarc-oza-31,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.759000,P18Y,,,,,,,,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd4a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Tibia, Primary, Fibroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7m9,pgxind-kftx33al,pgxcs-kftvtplb,960795565,0.334,423246068,0.147,537549497,0.187,PGX_AM_BS_OstSarc-oza-32,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.761000,P14Y,,,,,,,,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd4b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Tibia, Primary, Fibroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7ma,pgxind-kftx33an,pgxcs-kftvtplt,785190689,0.273,297811831,0.104,487378858,0.17,PGX_AM_BS_OstSarc-oza-33,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.762000,P22Y,,,,,,,,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd4c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mc,pgxind-kftx33ap,pgxcs-kftvtpma,1733374586,0.603,825134628,0.287,908239958,0.316,PGX_AM_BS_OstSarc-oza-34,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.764000,P15Y,,,,,,,,0,19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd4d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Pelvis-Sacrum-L5, Primary, Chondroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7me,pgxind-kftx33ar,pgxcs-kftvtpms,464831803,0.162,301793004,0.105,163038799,0.057,PGX_AM_BS_OstSarc-oza-35,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.765000,P10Y,,,,,,,,0,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd4e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Fibula, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mf,pgxind-kftx33au,pgxcs-kftvtpn9,2221143758,0.773,929870284,0.323,1291273474,0.449,PGX_AM_BS_OstSarc-oza-36,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.767000,P14Y,,,,,,,,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd4f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Fibula, Primary, Chondroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mh,pgxind-kftx33aw,pgxcs-kftvtpnq,1281988926,0.446,618196385,0.215,663792541,0.231,PGX_AM_BS_OstSarc-oza-37,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.768000,P11Y,,,,,,,,0,32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd50,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Tibia, Primary, Fibroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mj,pgxind-kftx33ay,pgxcs-kftvtpo8,1276029742,0.444,726560934,0.253,549468808,0.191,PGX_AM_BS_OstSarc-oza-38,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.769000,P5Y,,,,,,,,0,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd51,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Humerus, Primary, Chondroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7ml,pgxind-kftx33b0,pgxcs-kftvtpop,2067060142,0.719,960182460,0.334,1106877682,0.385,PGX_AM_BS_OstSarc-oza-39,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.771000,P16Y,,,,,,,,0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd52,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Femur, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mm,pgxind-kftx33b2,pgxcs-kftvtpp7,1834850234,0.638,856494751,0.298,978355483,0.34,PGX_AM_BS_OstSarc-oza-40,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.772000,P12Y,,,,,,,,0,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd53,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Tibia, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mo,pgxind-kftx33b4,pgxcs-kftvtppp,1137123759,0.396,296507969,0.103,840615790,0.292,PGX_AM_BS_OstSarc-oza-41,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.774000,P15Y,,,,,,,,0,43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd54,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Metastasis, Chondroblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mp,pgxind-kftx33b6,pgxcs-kftvtpq6,528746258,0.184,330257888,0.115,198488370,0.069,PGX_AM_BS_OstSarc-oza-42,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.775000,P40Y,,,,,,,,0,153,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd55,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Metastasis, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mr,pgxind-kftx33b8,pgxcs-kftvtpqn,1191760467,0.415,597536635,0.208,594223832,0.207,PGX_AM_BS_OstSarc-oza-43,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.777000,P51Y,,,,,,,,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd58,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Pubis Metastasis, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mw,pgxind-kftx33be,pgxcs-kftvtps4,331076108,0.115,150344403,0.052,180731705,0.063,PGX_AM_BS_OstSarc-oza-46,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.781000,P55Y,,,,,,,,0,40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae711,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Osteosarcoma [Extraskeletal],PMID:16170537,"Knuuttila A, Jee KJ et al. (2006): Spindle cell tumours of the pleura:...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C38.4,pleura,pgxbs-kftvh0hx,pgxind-kftx2ueb,pgxcs-kftvri0t,788306557,0.274,0,0,788306557,0.274,PGX_AM_BS_SpindlePleu-knu-06,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000977,pleura,{},2020-09-10 17:44:27.880000,P66Y,,,,,,,,1,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aef72,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Osteosarcoma [Osteoblastic],PMID:15305059,"Zielenska M, Marrano P et al. (2004): High-resolution cDNA microarray CGH mapping of...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh36l,pgxind-kftx2xr9,pgxcs-kftvsc21,234313990,0.082,7300008,0.003,227013982,0.079,PGX_AM_BS_OstSarc-zie-OS1P,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:30.860000,P13Y,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aef73,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Osteosarcoma [Osteoblastic],PMID:15305059,"Zielenska M, Marrano P et al. (2004): High-resolution cDNA microarray CGH mapping of...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh36n,pgxind-kftx2xrb,pgxcs-kftvsc2i,582784338,0.203,92091524,0.032,490692814,0.171,PGX_AM_BS_OstSarc-zie-OS2P,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:30.861000,P18Y,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c9727983b2e00aef74,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Osteosarcoma [Osteoblastic],PMID:15305059,"Zielenska M, Marrano P et al. (2004): High-resolution cDNA microarray CGH mapping of...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh36o,pgxind-kftx2xrd,pgxcs-kftvsc2z,24500023,0.009,0,0,24500023,0.009,PGX_AM_BS_OstSarc-zie-OS3P,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:30.863000,P59Y,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c9727983b2e00aef75,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Osteosarcoma [Osteoblastic],PMID:15305059,"Zielenska M, Marrano P et al. (2004): High-resolution cDNA microarray CGH mapping of...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh36q,pgxind-kftx2xrf,pgxcs-kftvsc3g,509391817,0.177,4700004,0.002,504691813,0.176,PGX_AM_BS_OstSarc-zie-OS4P,{},-79.42,43.7,Point,CAN,Toronto,Canada,"Toronto, Canada",43.7,-79.42,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:30.864000,P10Y,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd2b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7kv,pgxind-kftx338u,pgxcs-kftvtp6d,1203438907,0.419,584438288,0.203,619000619,0.215,PGX_AM_BS_OstSarc-oza-01,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.717000,P35Y,,,,,,,,1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd30,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Tibia, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7l3,pgxind-kftx3395,pgxcs-kftvtp8t,850675112,0.296,288202680,0.1,562472432,0.196,PGX_AM_BS_OstSarc-oza-06,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.724000,P13Y,,,,,,,,1,25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd32,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Ilium-Sacrum, Primary, Osteoblastic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7l6,pgxind-kftx3399,pgxcs-kftvtp9s,947961710,0.33,230585970,0.08,717375740,0.25,PGX_AM_BS_OstSarc-oza-08,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.727000,P42Y,,,,,,,,1,27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd37,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Ilium-Sacrum, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7le,pgxind-kftx339j,pgxcs-kftvtpc6,1161507906,0.404,518626044,0.18,642881862,0.224,PGX_AM_BS_OstSarc-oza-13,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.734000,P20Y,,,,,,,,1,20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd3a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Femur, Primary, Teleangiectatic]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lj,pgxind-kftx339p,pgxcs-kftvtpdm,0,0,0,0,0,0,PGX_AM_BS_OstSarc-oza-16,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.738000,P53Y,,,,,,,,1,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd3f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Primary]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7lr,pgxind-kftx339z,pgxcs-kftvtpg0,539472904,0.188,243333970,0.085,296138934,0.103,PGX_AM_BS_OstSarc-oza-21,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.745000,P6Y,,,,,,,,1,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56cb727983b2e00afd56,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Proximal Tibia, Metastasis]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mt,pgxind-kftx33ba,pgxcs-kftvtpr5,590286687,0.205,235849197,0.082,354437490,0.123,PGX_AM_BS_OstSarc-oza-44,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.778000,P33Y,,,,,,,,1,149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56cb727983b2e00afd57,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Osteosarcoma [Distal Femur, Recurrence, Extraskeletal]",PMID:12402305,"Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...",NCIT:C9145,Osteosarcoma,icdom-91803,"Osteosarcoma, NOS",icdot-C40.0,bones and joints,pgxbs-kftvh7mu,pgxind-kftx33bc,pgxcs-kftvtprn,1315893906,0.458,697918102,0.243,617975804,0.215,PGX_AM_BS_OstSarc-oza-45,{},7.63,51.96,Point,DEU,Muenster,Germany,"Muenster, Germany",51.96,7.63,city,Feature,EFO:0009656,neoplastic sample,UBERON:0004765,skeletal element,{},2020-09-10 17:44:35.780000,P53Y,,,,,,,,1,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae0e8,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Rhabdomyosarcoma [Sclerosing, pseudovascular]",PMID:17016719,"Kuhnen C, Herter P et al. (2006): Sclerosing pseudovascular rhabdomyosarcoma-immunohistochemical, ultrastructural, and genetic...",NCIT:C3359,Rhabdomyosarcoma,icdom-89003,"Rhabdomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgyio,pgxind-kftx2rxx,pgxcs-kftvqvzq,144044713,0.05,67927483,0.024,76117230,0.026,PGX_AM_BS_SclPsVasRMS-kuh,{},7.22,51.48,Point,DEU,Bochum,Germany,"Bochum, Germany",51.48,7.22,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:25.311000,P62Y,,,,,,,,0,10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae322,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,rhabdomyosarcoma,PMID:16790082,"Goldstein M, Meller I et al. (2006): Novel genes implicated in embryonal, alveolar,...",NCIT:C3359,Rhabdomyosarcoma,icdom-89003,"Rhabdomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgz8h,pgxind-kftx2su1,pgxcs-kftvr3wu,0,0,0,0,0,0,PGX_AM_BS_RMS-gol-ARMS3,,34.78,32.08,Point,ISR,Tel Aviv,Israel,"Tel Aviv, Israel",32.08,34.78,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.490000,P3Y,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae324,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,rhabdomyosarcoma,PMID:16790082,"Goldstein M, Meller I et al. (2006): Novel genes implicated in embryonal, alveolar,...",NCIT:C3359,Rhabdomyosarcoma,icdom-89003,"Rhabdomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgz8l,pgxind-kftx2su5,pgxcs-kftvr3xs,0,0,0,0,0,0,PGX_AM_BS_RMS-gol-ARMS7,,34.78,32.08,Point,ISR,Tel Aviv,Israel,"Tel Aviv, Israel",32.08,34.78,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.492000,P31Y,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae325,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,rhabdomyosarcoma,PMID:16790082,"Goldstein M, Meller I et al. (2006): Novel genes implicated in embryonal, alveolar,...",NCIT:C3359,Rhabdomyosarcoma,icdom-89003,"Rhabdomyosarcoma, NOS",icdot-C49.9,"connective and soft tissue, NOS",pgxbs-kftvgz8m,pgxind-kftx2su7,pgxcs-kftvr3y9,0,0,0,0,0,0,PGX_AM_BS_RMS-gol-ERMS2,,34.78,32.08,Point,ISR,Tel Aviv,Israel,"Tel Aviv, Israel",32.08,34.78,city,Feature,EFO:0009656,neoplastic sample,UBERON:0002384,connective tissue,{},2020-09-10 17:44:26.494000,P7Y,T1,NCITstage-C27966,Stage I,TNM-C48720,T1 Stage Finding,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c8727983b2e00ae710,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,"Smooth muscle tumour, malignant",PMID:16170537,"Knuuttila A, Jee KJ et al. (2006): Spindle cell tumours of the pleura:...",NCIT:C3359,Rhabdomyosarcoma,icdom-89003,"Rhabdomyosarcoma, NOS",icdot-C38.4,pleura,pgxbs-kftvh0hv,pgxind-kftx2ue9,pgxcs-kftvri0c,428633050,0.149,207640611,0.072,220992439,0.077,PGX_AM_BS_SpindlePleu-knu-05,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000977,pleura,{},2020-09-10 17:44:27.879000,P73Y,,,,,,,,1,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,M
5bab56c7727983b2e00ae474,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzno,pgxind-kftx2tcm,pgxcs-kftvr8n6,0,0,0,0,0,0,PGX_AM_BS_LMS-sva-33,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.951000,P64Y,,,,,,,,0,16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae475,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgznp,pgxind-kftx2tco,pgxcs-kftvr8nn,1620667386,0.564,773129923,0.269,847537463,0.295,PGX_AM_BS_LMS-sva-34,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.953000,P75Y,,,,,,,,0,12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae476,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgznr,pgxind-kftx2tcq,pgxcs-kftvr8o5,674937481,0.235,542587814,0.189,132349667,0.046,PGX_AM_BS_LMS-sva-35,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.954000,P42Y,,,,,,,,0,86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae477,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgznt,pgxind-kftx2tcs,pgxcs-kftvr8om,0,0,0,0,0,0,PGX_AM_BS_LMS-sva-36,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.956000,P40Y,,,,,,,,0,56.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae479,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgznw,pgxind-kftx2tcw,pgxcs-kftvr8pl,162027416,0.056,88827343,0.031,73200073,0.025,PGX_AM_BS_LMS-sva-38,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.958000,P49Y,,,,,,,,0,28.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae47a,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgznx,pgxind-kftx2tcy,pgxcs-kftvr8q2,0,0,0,0,0,0,PGX_AM_BS_LMS-sva-39,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.960000,P34Y,,,,,,,,0,54.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae47d,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzo2,pgxind-kftx2td4,pgxcs-kftvr8ri,908783586,0.316,565920144,0.197,342863442,0.119,PGX_AM_BS_LMS-sva-42,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.964000,P58Y,,,,,,,,0,26.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae481,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzo9,pgxind-kftx2tdc,pgxcs-kftvr8tf,607720436,0.211,335018058,0.117,272702378,0.095,PGX_AM_BS_LMS-sva-46,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.969000,P38Y,,,,,,,,0,41.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae484,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzoe,pgxind-kftx2tdi,pgxcs-kftvr8uv,1006998480,0.35,226479867,0.079,780518613,0.271,PGX_AM_BS_LMS-sva-49,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.973000,P38Y,,,,,,,,0,9.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae478,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgznu,pgxind-kftx2tcu,pgxcs-kftvr8p3,893155207,0.311,619762715,0.216,273392492,0.095,PGX_AM_BS_LMS-sva-37,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.957000,P48Y,,,,,,,,1,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae47b,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgznz,pgxind-kftx2td0,pgxcs-kftvr8qj,941220220,0.327,566020781,0.197,375199439,0.131,PGX_AM_BS_LMS-sva-40,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.961000,P69Y,,,,,,,,1,25.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae47c,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzo1,pgxind-kftx2td2,pgxcs-kftvr8r1,173508646,0.06,87213842,0.03,86294804,0.03,PGX_AM_BS_LMS-sva-41,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.962000,P69Y,,,,,,,,1,35.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae47e,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzo4,pgxind-kftx2td6,pgxcs-kftvr8rz,832085086,0.289,691418256,0.24,140666830,0.049,PGX_AM_BS_LMS-sva-43,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.965000,P71Y,,,,,,,,1,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae47f,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzo5,pgxind-kftx2td8,pgxcs-kftvr8sg,220344682,0.077,120405945,0.042,99938737,0.035,PGX_AM_BS_LMS-sva-44,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.966000,P70Y,,,,,,,,1,81.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae480,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzo7,pgxind-kftx2tda,pgxcs-kftvr8sy,297062413,0.103,102893633,0.036,194168780,0.068,PGX_AM_BS_LMS-sva-45,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.968000,P64Y,,,,,,,,1,4.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae482,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzoa,pgxind-kftx2tde,pgxcs-kftvr8tw,1482766749,0.516,814830231,0.283,667936518,0.232,PGX_AM_BS_LMS-sva-47,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.971000,P64Y,,,,,,,,1,64.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae483,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzoc,pgxind-kftx2tdg,pgxcs-kftvr8ue,1134287499,0.395,773623435,0.269,360664064,0.125,PGX_AM_BS_LMS-sva-48,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.972000,P69Y,,,,,,,,1,121.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae485,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzof,pgxind-kftx2tdk,pgxcs-kftvr8vd,2094418516,0.728,1203911998,0.419,890506518,0.31,PGX_AM_BS_LMS-sva-50,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.975000,P53Y,,,,,,,,1,21.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F
5bab56c7727983b2e00ae486,pgxcohort-2021progenetix,Version at Progenetix Update 2021,DUO:0000004,no restriction,Leiomyosarcoma,PMID:16648866,"Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...",NCIT:C6340,Uterine Corpus Leiomyosarcoma,icdom-88903,"Leiomyosarcoma, NOS",icdot-C55.9,"uterus, nos",pgxbs-kftvgzoh,pgxind-kftx2tdm,pgxcs-kftvr8vu,1203902361,0.419,156329167,0.054,1047573194,0.364,PGX_AM_BS_LMS-sva-51,{},24.94,60.17,Point,FIN,Helsinki,Finland,"Helsinki, Finland",60.17,24.94,city,Feature,EFO:0009656,neoplastic sample,UBERON:0000995,uterus,{},2020-09-10 17:44:26.977000,P81Y,,,,,,,,1,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,F